An unidentified worker checks vials of insulin at the Novo Nordisk factory in Kalundborg, Denmark. A Kansas City-based researcher led a study published this week that found that the company’s new long-acting insulin cut hypoglycemic diabetic emergencies by 40 percent.
An unidentified worker checks vials of insulin at the Novo Nordisk factory in Kalundborg, Denmark. A Kansas City-based researcher led a study published this week that found that the company’s new long-acting insulin cut hypoglycemic diabetic emergencies by 40 percent. Novo Nordisk via Bloomberg News.
An unidentified worker checks vials of insulin at the Novo Nordisk factory in Kalundborg, Denmark. A Kansas City-based researcher led a study published this week that found that the company’s new long-acting insulin cut hypoglycemic diabetic emergencies by 40 percent. Novo Nordisk via Bloomberg News.

HCA Midwest researcher’s insulin study finds reductions in diabetic emergencies

June 13, 2017 12:18 PM

More Videos

  • Local groups step in when national dollars for marketplace insurance ads cut.

    Health insurance navigators from across the KC metro star in a new TV commercial to promote open enrollment in the Marketplace. Trump cut advertising dollars for ACA, so local groups stepped in.